Monthly information on share capital and company voting rights

Cellectis (CLLS) reported its monthly share capital and voting rights totals as of September 30, 2026.

(Moderate)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Cellectis (CLLS) reported its monthly share capital and voting rights totals as of September 30, 2026.

The company had 100,732,781 shares in its capital and 105,563,044 voting rights on that date. The disclosure falls under Article 223-16 of the French financial markets authority’s General Regulation.

Key Figures

Shares in capital: 100,732,781 shares Voting rights: 105,563,044 voting rights

Shares in capital: 100,732,781 shares; As of September 30, 2026
Voting rights: 105,563,044 voting rights; As of September 30, 2026

Key Terms

isin code

1 terms

isin code financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/06/2026 - 04:30 PM

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
09/30/2026	100,732,781	105,563,044

For further information on Cellectis, please contact:        

Media contacts:             
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93     
   
Investor Relations contact:          
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com  

Attachment